<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>RSS News Feed for Ultrafine - from Laboratorytalk</title>
    <link>http://www.laboratorytalk.com/news/ult/ult000.html</link>
    <description>Ultrafine news releases on Laboratorytalk</description>
    <language>en-gb</language>
    <copyright>Copyright (C)2008 Pro-Talk Ltd. All rights reserved.</copyright>
    <pubDate>Fri, 25 Jul 2008 08:00:00 UT</pubDate>
    <lastBuildDate>Fri, 25 Jul 2008 08:00:00 UT</lastBuildDate>
    <image>
      <title>Pro-Talk Ltd</title>
      <url>http://www.pro-talk.com/images/protalklogo90.gif</url>
      <link>http://www.pro-talk.com/</link>
      <width>90</width>
      <height>79</height>
    </image>
    <item>
      <title>Scale up for arthritis drug</title>
      <description>Avidex has announced the appointment of Ultrafine to provide process development, scale-up and GMP manufacturing for Avidex's lead compound, the CD80 inhibitor, RhuDex</description>
      <pubDate>Wed, 24 Mar 2004 08:00:00 UT</pubDate>
      <category>Ultrafine</category>
      <link>http://www.laboratorytalk.com/news/ult/ult104.html</link>
    </item>
    <item>
      <title>Phase 1 candidate produced to GMP</title>
      <description>Involvement started when the chemistry was initially transferred, through to scale-up and production of pre-clinical material, and subsequent GMP manufacture</description>
      <pubDate>Thu, 12 Feb 2004 08:00:00 UT</pubDate>
      <category>Ultrafine</category>
      <link>http://www.laboratorytalk.com/news/ult/ult103.html</link>
    </item>
    <item>
      <title>Developing neuropathic pain candidate</title>
      <description>First phase of chemical process development and scale-up for drug candidate to treat disease of multiple aetiology has been completed</description>
      <pubDate>Wed, 17 Dec 2003 08:00:00 UT</pubDate>
      <category>Ultrafine</category>
      <link>http://www.laboratorytalk.com/news/ult/ult102.html</link>
    </item>
    <item>
      <title>New head of chemical operations</title>
      <description>Ultrafine appoints Rick Dyer as head of chemical operations, while Mike Harris now becomes head of business development</description>
      <pubDate>Thu, 06 Feb 2003 08:00:00 UT</pubDate>
      <category>Ultrafine</category>
      <link>http://www.laboratorytalk.com/news/ult/ult101.html</link>
    </item>
    <item>
      <title>Creating the 'smartest' chemistry</title>
      <description>Ultrafine, specialist in contract chemistry research and custom synthesis for the pharmaceutical and biotechnology industries, has been presented with a DTi Smart Award</description>
      <pubDate>Fri, 27 Jul 2001 08:00:00 UT</pubDate>
      <category>Ultrafine</category>
      <link>http://www.laboratorytalk.com/news/ult/ult100.html</link>
    </item>
  </channel>
</rss>
